Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

June 11 On June 3, the Biden administration issued Executive Order 14032, which amends Executive Order 13959 issued by the… twitter.com/i/web/status/1…
June 10 On June 7, 2021, Securities and Exchange Commission Chair Gary Gensler identified several areas of focus for SEC st… twitter.com/i/web/status/1…
June 9 Partners Karen Lent and Kenneth Schwartz discuss the potential for using antitrust enforcement to promote systemic… twitter.com/i/web/status/1…